Company Number: 15163371

Analysis Date: 2025-07-20 18:48 UTC

1. Executive Summary
   SSB PHARMA LTD is a newly established, micro-entity operating as a dispensing chemist in specialised stores. With a sole director and owner, the company currently operates with minimal financial scale and workforce, positioning itself as a niche player in the pharmaceutical retail sector.

2. Strategic Assets

• Niche Market Focus: The company’s classification under SIC code 47730 indicates a specialization in dispensing chemist services, which can foster strong customer loyalty and specialized service differentiation.
• Lean Operations: With only one employee and limited liabilities, the company maintains low overheads, enabling operational flexibility and cost control.
• Full Control by Founder: Mr. Murtaza Iqbal owns 75-100% of shares and voting rights, allowing for swift decision-making and agile strategic adjustments without external shareholder conflicts.
• Healthy Working Capital: Net current assets of £12,679 suggest positive short-term liquidity, providing a buffer for initial operational expenses and growth investments.

3. Growth Opportunities

• Geographic Expansion: Leveraging the local presence in Cheadle and Gatley, the company could explore opening additional specialised dispensing outlets in nearby underserved regions.
• Service Diversification: Introducing complementary services such as health consultations, vaccinations, or chronic disease management could enhance customer value and revenue streams.
• Digital Integration: Developing an online platform for prescription management and home delivery services would tap into growing consumer demand for convenience and accessibility.
• Strategic Partnerships: Collaborations with healthcare providers, clinics, or care homes could create referral networks and steady demand pipelines.

4. Strategic Risks

• Scale Limitations: As a micro-entity with a single employee and modest assets, scaling operations sustainably will require significant capital and human resource investment.
• Regulatory Compliance: Operating within a highly regulated pharmaceutical sector necessitates strict adherence to legal and safety standards, which could strain limited internal resources.
• Market Competition: Larger pharmacy chains and online competitors with extensive resources pose a threat to customer acquisition and retention in specialised dispensing.
• Owner-Dependent Management: Heavy reliance on a single director and owner increases operational risk, especially in scenarios of absence or health issues, potentially impacting business continuity.
• Financial Constraints: The company’s initial modest asset base may limit its ability to invest aggressively in growth initiatives without external funding.